La Jolla Pharmaceutical (LJPC) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts LJPC Hot Sheet
Join SI Premium – FREE
La Jolla Pharmaceutical (NASDAQ: LJPC) reported Q3 EPS of ($0.70), $0.01 better than the analyst estimate of ($0.71).
For earnings history and earnings-related data on La Jolla Pharmaceutical (LJPC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
- Coty (COTY) Misses Q4 EPS by 1c, offers outlook
- Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
